Arcadia Biosciences (RKDA) Misses Q3 EPS by 4c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.11), $0.04 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c